Furthermore, since consumption of intact complement components (e.g. C3, C4 and C5) can paradoxically reduce plasma levels during strong complement activation [38], future measurements of activated fragments (e.g. C3a, C3b and components of the TCC) in FTD might provide more robust measures of peripheral complement activation. This evidence concerns the gene C4A and frontotemporal dementia.